EUVIMEDEUVIMED entdecken
Crossref

Expanding the genetic landscape of moyamoya angiopathy: insights from 74 trios

Chaker Aloui iD, Manoelle Kossorotoff, Dominique Hervé, Markus Kraemer, Florence Riant, Stéphanie Guey, Juyeon Ko, Jinsung Kim, Lily Y Jan, Mickaelle Corpechot, Thibault Coste iD, Sandro Benichi und 4 weitere

Brain · 11.11.2026

DOI: 10.1093/brain/awag393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 11.11.2026. Verfasst von Chaker Aloui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, 75013 Paris, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moyamoya angiopathy (MMA) is a rare cerebrovascular disorder characterized by progressive stenosis of intracranial arteries and the development of abnormal collateral vessels. While RNF213 is a major susceptibility gene in East Asian populations, the genetic architecture of MMA beyond RNF213, particularly in Europeans, remains largely undefined beyond a few known syndromic causes. We performed whole-exome sequencing on 74 sporadic MMA trios (proband and unaffected parents) of predominantly European ancestry. An additional cohort of 200 probands was screened for gene recurrence. We applied a stringent filtering strategy to identify de novo and rare inherited variants, followed by gene prioritization based on structural modeling, expression data, and biological plausibility. Gene-based burden tests were conducted against large control databases (gnomAD). We identified causative variants in 20 of the 74 probands (27%). Six probands with severe syndromic infant-onset phenotypes harbored de novo variants in the E3 ligase domain of RNF213. Fourteen probands carried a causative copy number variant (n = 3) or a short variant (n = 11) in a known MMA-associated gene (CBL, NF1, PTPN11, DIAPH1, ANO1, JAG1, NOS3, HBB). Beyond these established genes, we identified strong candidate variants in 11 probands from the discovery cohort, involving 11 novel candidate genes. Screening the additional cohort of 200 unrelated MMA probands identified recurrence of the gain-of-function SMAD4 p.Arg496Cys variant, which was de novo in the discovery-cohort proband, linking MMA to dysregulated TGF-β signaling. Other candidate findings included de novo loss-of-function variants in genes regulating epigenetic modulation and RNA splicing (SETD2, HNRNPL, UBAP2L, TOP2B, PRPF40A) and variants affecting vascular stress response (EPAS1, SVEP1, PDCD4). RNF213 was the only gene reaching exome-wide significance in burden testing (P = 2.11 × 10⁻11). This study establishes that MMA in non-East Asian populations is characterized by a strong genetic heterogeneity. These findings expand the molecular landscape of MMA and highlight the utility of trio-based sequencing for uncovering very rare molecular players in this disease. Additional analyses will now be needed to investigate the convergence of MMA pathways.

Schlagwörter

Stichwörter der Autor:innen

RNF213SMAD4moyamoya angiopathymoyamoya novel genespediatric strokewhole-exome sequencing

Autor:innen und Institutionen

  • Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, 75013 Paris, France.
  • National center for rare pediatric cerebrovascular diseases (CERVCO), Necker-Enfants malades University Hospital, APHP, Inserm U1266, IPNP, 75015 Paris, France.
  • CNVT-CERVCO, Lariboisière Hospital, APHP, Université Paris Cité, Inserm UMRS-1144, VASCERN, 75010 Paris, France.
  • Department of Neurology, Alfried Krupp Hospital, 45130 Essen, Germany.
  • Clinic of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
  • Department of Medical Genetics, APHP, Hôpital de la Pitié-Salpêtrière, Sorbonne Université, 75013 Paris, France.

ORCID-Profile: Chaker Aloui, Thibault Coste

Zitieren

APA

Aloui, C., Kossorotoff, M., Hervé, D., Kraemer, M., Riant, F., Guey, S., Ko, J., Kim, J., Jan, L. Y., Corpechot, M., Coste, T., Benichi, S., Bellesme, C., Khadra, E., Bergametti, F., & Tournier-Lasserve, E. (2026). Expanding the genetic landscape of moyamoya angiopathy: insights from 74 trios. Brain. https://doi.org/10.1093/brain/awag393

Vancouver

Aloui C, Kossorotoff M, Hervé D, Kraemer M, Riant F, Guey S, et al. Expanding the genetic landscape of moyamoya angiopathy: insights from 74 trios. Brain. 2026. doi:10.1093/brain/awag393

BibTeX
@article{Aloui2026,
  author = {Aloui, Chaker and Kossorotoff, Manoelle and Hervé, Dominique and Kraemer, Markus and Riant, Florence and Guey, Stéphanie and Ko, Juyeon and Kim, Jinsung and Jan, Lily Y and Corpechot, Mickaelle and Coste, Thibault and Benichi, Sandro and Bellesme, Céline and Khadra, Elissa and Bergametti, Françoise and Tournier-Lasserve, Elisabeth},
  title = {Expanding the genetic landscape of moyamoya angiopathy: insights from 74 trios},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag393}
}
Kostenlos starten →